Mechanisms of Clinical Resistance to 5-Fluorouracil Chemotherapy
- 1 January 1996
- book chapter
- Published by Springer Nature
- Vol. 87, 175-195
- https://doi.org/10.1007/978-1-4613-1267-3_7
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Preclinical and clinical aspects of biomodulation of 5-fluorouracilCancer Treatment Reviews, 1994
- Quinazoline antifolates inhibiting thymidylate synthase: 2-desamino derivatives with enhanced solubility and potencyJournal of Medicinal Chemistry, 1989
- Phase II study of the antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717) in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Concurrent allopurinol and 5-fluorouracil: 5-fluoro-2?-deoxyuridylate formation and thymidylate synthase inhibition in rat colon carcinoma and in regenerating rat liverCancer Chemotherapy and Pharmacology, 1987
- Identification of poly G bound to thymidylate synthaseBiochemical and Biophysical Research Communications, 1986
- Nucleoside and nucleotide inactivation of R17 coat protein: evidence for a transient covalent RNA-protein bondBiochemistry, 1985
- Sequence-specific interaction of R17 coat protein with its ribonucleic acid binding siteBiochemistry, 1983
- A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in micePublished by Elsevier ,1981
- Nucleotide Sequence at the Binding Site for Coat Protein on RNA of Bacteriophage R17Proceedings of the National Academy of Sciences, 1972
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957